AMS has access to GMP approved facilities and licenses via its strategic partnership with PozLab.
Specifically, the available license comprises solid dosage forms and asssociated intermediates. The facilities are approved for: manufacturing, release of raw materials, release of intermediates and release of final pharmaceutical products, including stability and solid state characterisation